Life ScienceCompany
JT Pharmaceuticals - kappa opioid agonist peptide Ownership
Who owns JT Pharmaceuticals - kappa opioid agonist peptide?
JT Pharmaceuticals - kappa opioid agonist peptide is owned by Titan Pharmaceuticals. It was acquired on October 28, 2020.
JT Pharmaceuticals - kappa opioid agonist peptide Business Overview
Where is JT Pharmaceuticals - kappa opioid agonist peptide headquartered?
JT Pharmaceuticals - kappa opioid agonist peptide is headquartered in Mt. Pleasant, South Carolina.
What sector is JT Pharmaceuticals - kappa opioid agonist peptide in?
JT Pharmaceuticals - kappa opioid agonist peptide is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.